Skip to main content

Table 3 Clinical ICU course

From: Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

Characteristics

Overall

(N = 51)

Early empiric treatment

(n = 31)

Definitive treatment

(n = 20)

P value

New development of organ failurea

 Shock

30 (58.8)

20 (64.5)

10 (50.0)

0.461

 Renal failure requiring renal replacement therapy

13 (25.5)

6 (19.4)

7 (35.0)

0.356

 Extracorporeal membrane oxygenation

2 (3.9)

2 (6.5)

0 (0.0)

0.674

Outcomes

 ICU mortality

19 (37.3)

13 (41.9)

6 (30.0)

0.573

 Length of stay in ICU (days)

15.0 (6.0–29.0)

18.0 (8.5–30.5)

11.0 (5.0–19.0)

0.162

 Hospital mortality

23 (45.1)

15 (48.4)

8 (40.0)

0.765

 Length of stay in hospital (days)

24.0 (15.5–32.5)

25.0 (16.0–34.5)

20.5 (15.5–32.0)

0.493

  1. Data are presented as number (percentage) or as median (interquartile range)
  2. ICU intensive care units
  3. aTwo patients developed shock and renal failure requiring both renal replacement therapy and extracorporeal membrane oxygenation support. Eight patients developed both shock and renal failure requiring renal replacement therapy